Amaya
Belanger Quintana
Profesor/a Asociado/a en CC. de la Salud
University Hospital Heidelberg
Heidelberg, AlemaniaPublicacións en colaboración con investigadores/as de University Hospital Heidelberg (10)
2021
-
Defining tetrahydrobiopterin responsiveness in phenylketonuria: Survey results from 38 countries
Molecular Genetics and Metabolism, Vol. 132, Núm. 4, pp. 215-219
2020
-
The Genetic Landscape and Epidemiology of Phenylketonuria
American Journal of Human Genetics, Vol. 107, Núm. 2, pp. 234-250
2017
-
Issues with European guidelines for phenylketonuria – Authors' reply
The Lancet Diabetes and Endocrinology
-
Key European guidelines for the diagnosis and management of patients with phenylketonuria
The Lancet Diabetes and Endocrinology, Vol. 5, Núm. 9, pp. 743-756
-
The complete European guidelines on phenylketonuria: Diagnosis and treatment
Orphanet Journal of Rare Diseases, Vol. 12, Núm. 1
2016
-
Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results
European Journal of Pediatrics, Vol. 175, Núm. 2, pp. 261-272
2015
-
Tetrahydrobiopterin (BH4) responsiveness in neonates with hyperphenylalaninemia: A semi-mechanistically-based, nonlinear mixed-effect modeling
Molecular Genetics and Metabolism, Vol. 114, Núm. 4, pp. 564-569
-
The challenges of managing coexistent disorders with phenylketonuria: 30 cases
Molecular Genetics and Metabolism, Vol. 116, Núm. 4, pp. 242-251
2013
-
Fluctuations in phenylalanine concentrations in phenylketonuria: A review of possible relationships with outcomes
Molecular Genetics and Metabolism, Vol. 110, Núm. 4, pp. 418-423
-
Long-term follow-up and outcome of phenylketonuria patients on sapropterin: A retrospective study
Pediatrics, Vol. 131, Núm. 6